Latest Versant Venture Management, LLC Stock Portfolio
$162Million | No. of Holdings #8
Versant Venture Management, LLC Performance
2026 Q2+21.84%
YTD+9.67%
2025-28.54%
About Versant Venture Management, LLC and 13F Hedge Fund Stock Holdings
On 2026-08-12, the fund reported it's updated stock portfolio. In the 13F Holdings report, Versant Venture Management, LLC reported an equity portfolio of $162.6 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Versant Venture Management, LLC are GLUE, IPSC, AVTE. The fund has invested 47.3% of it's portfolio in MONTE ROSA THERAPEUTICS, INC. and 18.3% of portfolio in CENTURY THERAPEUTICS, INC. <br><br> They significantly reduced their stock positions in JADE BIOSCIENCES, INC. (AVTE).
Versant Venture Management, LLC Equity Portfolio Value
Last Reported on: 12 Aug, 2026
$162Million
as of Aug 12, 2026Versant Venture Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Versant Venture Management, LLC made a return of 21.84% in the last quarter. In trailing 12 months, it's portfolio return was -0.21%.
- Performance
- S&P 500
New Buys
No new stocks were added by Versant Venture Management, LLC
Additions
No additions were made to existing positions by Versant Venture Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| jade biosciences, inc. | -35.00 |
Versant Venture Management, LLC reduced stake in above stock
Sold off
None of the stocks were completely sold off by Versant Venture Management, LLC
Sector Distribution
Versant Venture Management, LLC has about 84.4% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 84.4 |
| Others | 15.6 |
Market Cap. Distribution
Versant Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- UNALLOCATED
- MID-CAP
| Category | % |
|---|---|
| SMALL-CAP | 79.2 |
| UNALLOCATED | 15.6 |
| MID-CAP | 5 |
Stocks belong to which Index?
About 79.2% of the stocks held by Versant Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 79.2 |
| Others | 20.8 |
Versant Venture Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Versant Venture Management, LLC
Versant Venture Management, LLC has 8 stocks in it's portfolio. proved to be the most loss making stock for the portfolio. GLUE was the most profitable stock for Versant Venture Management, LLC last quarter.
$162.61MTotal Value
8.00Positions
12 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Jade Biosciences, Inc. Versant Venture Management, LLC's holding in Jade Biosciences, Inc. over time | 13.55% | 991,783 | $22.04M 13.55% | 35%decreased 35 percentreduced | |
 Crispr Therapeutics Ag Versant Venture Management, LLC's holding in Crispr Therapeutics Ag over time | 4.99% | 148,831 | $8.12M 4.99% | 0%unchanged 0 percentunchanged | |
 Monte Rosa Therapeutics, Inc. Versant Venture Management, LLC's holding in Monte Rosa Therapeutics, Inc. over time | 47.34% | 3,180,780 | $76.97M 47.34% | 0%unchanged 0 percentunchanged | |
 Century Therapeutics, Inc. Versant Venture Management, LLC's holding in Century Therapeutics, Inc. over time | 18.33% | 12,166,100 | $29.81M 18.33% | 0%unchanged 0 percentunchanged | |
 SKYE Skye Bioscience, Inc.Skye Bioscience, Inc.SKYE | 0.86% | 2,007,700 | $1.39M 0.86% | 0%unchanged 0 percentunchanged | |
 Tempest Therapeutics, Inc. Versant Venture Management, LLC's holding in Tempest Therapeutics, Inc. over time | 0.18% | 269,772 | $299.4K 0.18% | 0%unchanged 0 percentunchanged | |
Common Stock Lenz Therapeutics, Inc. Lenz Therapeutics, Inc. | 9.28% | 2,656,890 | $15.09M 9.28% | 0%unchanged 0 percentunchanged | |
Common Stock Contineum Therapeutics, Inc.Contineum Therapeutics, Inc. | 5.47% | 542,628 | $8.89M 5.47% | 0%unchanged 0 percentunchanged | |